TL;DR
Get workout gear delivered free — and shop member deals
- Fast, free delivery on millions of items
- Access to Prime Big Deal Days deals on October 6–7
- Prime Video, Amazon Music and more included
A new Veterans Affairs policy will require younger veterans to sign consent forms and discuss antidepressant risks and benefits before receiving prescriptions. Separate studies reported that an investigational smartphone app reduced negative-symptom severity in schizophrenia and that people with major depression had lower scores after reducing ultraprocessed foods in a small pilot trial. The available summaries do not give the policy’s age range or detailed study results.
The Department of Veterans Affairs will require younger veterans to sign consent forms and have documented discussions about antidepressant risks and benefits before receiving a prescription, according to a report summarized by Medpage Today on September 30, 2026. The same roundup highlighted a randomized trial of an investigational app for schizophrenia and a small dietary pilot study in major depression, findings that may inform care but do not establish that either approach works for every patient.
The VA policy adds a formal consent step for younger veterans seeking antidepressants. The summary, citing The New York Times, says providers must document discussions of the medicines’ risks and benefits and obtain signed consent before prescribing. It does not state which ages qualify as younger veterans, when the policy takes effect, or whether it changes which medicines clinicians may prescribe.
In a separate study published in JAMA Network Open, an investigational smartphone app reduced the severity of negative symptoms in people with schizophrenia in a randomized trial, according to the roundup. Negative symptoms can include reduced motivation or social engagement. The supplied report gives no participant count, size of the effect, length of follow-up, or details about the app, so the result cannot be assessed beyond the summary.
A small pilot crossover trial reported in JAMA Psychiatry found lower depression and anxiety scores among people with major depressive disorder when they reduced ultraprocessed foods in their diet. A crossover design allows participants to experience more than one study condition, but the summary does not provide the number of participants, duration, or size of the score changes. The finding describes an association observed during the trial; it does not establish diet as a replacement for clinical treatment.
Consent and New Care Options
The VA rule could change how younger veterans and clinicians discuss antidepressant treatment by making written consent and a recorded risk-benefit discussion prerequisites to a prescription. That may affect the timing and documentation of care. The available account does not explain the policy’s rationale or how it will be applied in urgent situations, so its practical effect is not yet clear.
The two studies address possible additions to mental health care: a digital tool targeting schizophrenia symptoms and a dietary change studied in depression. For patients and clinicians, the results are early signals rather than treatment instructions. The app finding comes from a randomized trial, while the dietary result comes from a small pilot; without details on effect size and follow-up, readers cannot tell how durable or clinically meaningful the reported score changes were.
Three Developments in Psychiatry
The three items appeared in a Medpage Today psychiatry roundup dated September 30, 2026, which drew on coverage and research from several outlets. The VA policy was attributed to a New York Times report; the app and diet findings were attributed to papers in JAMA Network Open and JAMA Psychiatry, respectively.
The roundup also described other mental health developments, including suicide-related reports and a study of antipsychotic adherence in young adults with first-episode psychosis. Those items provide a broader picture of current reporting, but they do not establish a direct connection to the VA policy or to the app and diet studies. The three developments covered here concern different populations and interventions.
“The VA policy requires signed consent and documented discussions about antidepressant risks and benefits before younger veterans receive a prescription.”
— Medpage Today, summarizing a New York Times report
Policy Scope and Study Limits
Key details of the VA policy remain unavailable in the supplied report: the definition of younger veterans, the effective date, the consent process, and any exceptions. It is also unclear whether the policy applies to all antidepressants or settings in the same way.
The app and diet findings need fuller study details before their reach can be judged. The summaries omit participant numbers, effect sizes and follow-up periods, and they do not say whether benefits persisted after the interventions ended. The dietary study is described as small, and the app is investigational; neither summary establishes that these approaches should replace existing care. No direct comparison among the three developments is possible because they involve separate policies and studies.
Implementation and Follow-Up Evidence
The next practical milestone for the VA policy is clarification of its age range, start date and procedures for clinicians and veterans. The cited summary does not identify a rollout schedule or additional VA guidance.
For the app and dietary intervention, fuller results and further research would help show who may benefit, how large any effects are, and whether they last. Until those details are available, the reported findings should be read as study results rather than general treatment guidance. The supplied roundup does not name a next trial date or a planned VA update.
Key Questions
What does the new VA antidepressant policy require?
According to the report summarized by Medpage Today, younger veterans must sign consent forms and have documented discussions about antidepressant risks and benefits before receiving a prescription.
Which veterans are covered by the policy?
The supplied summary does not define the age range for “younger veterans,” and it does not specify the policy’s effective date.
What did the schizophrenia app trial find?
A randomized trial reported that an investigational smartphone app reduced the severity of negative symptoms. The summary does not provide the effect size, participant count or follow-up period.
Does the diet study show that changing food choices treats depression?
No such conclusion is established by the supplied summary. A small pilot crossover trial reported lower depression and anxiety scores when participants with major depressive disorder reduced ultraprocessed foods, but the summary gives no effect size or duration and does not show that diet replaces clinical care.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
